We are GRAPH
GRAPH is a boutique strategy consulting firm that supports leading global corporations, private equity and credit investors to invest in and build stronger businesses. We adopt a rigorous, evidence-based approach to identify market opportunities, conduct commercial due diligence and design winning growth strategies. READ MORE
Field Report from the 2023 HLTH Conference
Trends in healthcare information technology (HCIT) are continually evolving to enhance patient care and streamline healthcare processes. Here is an overview of the investment trends and opportunities that I found most compelling... READ MORE
GRAPH provides guidance on commercial diligence best practice and shares insights freely with our clients and peer community. Read our latest GRAPH Papers
James Tetherton Featured in Real Deals UK Midmarket Report 2023
James Tetherton was recently featured in Real Deals for their 2023 UK Midmarket Report discussing midmarket private equity industry. READ MORE
Diligence Matters® - a toolkit that helps active buyers strategically assess the merits of making an acquisition or other large commercial investment (e.g., expanding into a new market) through a well-considered commercial diligence exercise Diligence | Matters® toolkit
050 GRAPH Paper: CDD for Tech Implementation & Support Businesses
Given the massive growth in digitisation, automation and the software markets, investors are pushing ever-increasing amounts in the tech advisor and technology implementation/support partner market. READ MORE
Jack of All Trades, Master of None: The SaaS Breadth vs. Depth Diligence Dilemma
What do you want to be when you grow up? This classic question isn’t often examined when it comes to tech (and SaaS) companies seeking growth equity capital.
Diligence Considerations for Healthcare Provider Investments
Private equity interest and deal activity for healthcare providers has certainly accelerated over the past decade. Platform acquisitions are particularly targeted as opportunities for back-office efficiency and revenue growth – and to address pricing power imbalances with the ever-focused payers.
Access all of our recent news including deals supported by GRAPH and firm news.